Comparison of the efficacy of TXNDC5 monoclonal antibody versus conventional drugs in the treatment of intestinal fibrosis associated with inflammatory bowel disease
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.